Investor Alert: Understanding the Class Action Lawsuit
In recent news, investors in Applied Therapeutics, Inc. face heightened concerns due to a potential class action lawsuit. Levi & Korsinsky, LLP has alerted shareholders about the legal steps being taken in relation to alleged securities fraud during a specific timeframe.
Details of the Class Action Lawsuit
The lawsuit aims to recover losses incurred by Applied Therapeutics investors due to purported securities fraud. This action focuses on transactions that took place between early January and early December of the past year. If you are a shareholder during this period, it's imperative to understand your rights and options.
Impact of the Company’s Disclosure
Recent communications from Applied Therapeutics revealed that on November 27, the company issued a press release concerning the FDA's decision regarding their New Drug Application (NDA) for govorestat. This announcement marked a significant event, impacting not only the company's stock value but also instigating investor dissatisfaction due to the FDA's denotation of the application deficiencies.
Stock Price Fluctuations
Following the FDA's response, a drastic decline in Applied Therapeutics' stock was observed. The price plummeted from $10.21 per share to a low of $1.29 merely days later. Such fluctuations underscore the gravity of the situation and the urgency for shareholders affected to act swiftly.
Your Rights as a Shareholder
If you have experienced losses as a result of these developments, you have the right to seek recovery. Shareholders are encouraged to consider filing a request before the court's deadline. This step is crucial for those looking to become lead plaintiffs, although participation in the class action does not necessarily require this role.
No Financial Burden
Participating in this class action entails no out-of-pocket expenses for members. This provision allows affected shareholders the opportunity to recover losses without the concern of incurring costs. Thus, if you qualify, consider this as a viable option to reclaim investments.
Why Choose Levi & Korsinsky?
Levi & Korsinsky is recognized for its impressive track record in securities litigation, having secured substantial victories for its clients over the past two decades. Their expertise positions them as a reliable ally for shareholders navigating these turbulent waters.
Contact Information for Assistance
Shareholders looking for additional information or support related to this class action can reach out to Levi & Korsinsky. Joseph E. Levi, Esq. can be contacted via telephone at (212) 363-7500 or through email.
Frequently Asked Questions
What is the class action lawsuit against Applied Therapeutics?
The class action lawsuit is a legal action taken on behalf of investors who have suffered losses due to alleged securities fraud in the company.
What period does the lawsuit cover?
It specifically involves events between January 3, 2024, and December 2, 2024.
How will I know if I qualify as a class member?
If you were a shareholder during the specified period and incurred losses, you likely qualify as a class member.
What should I do if I want to participate?
If interested, you must make your intentions known to the court before the stated deadline.
Is there any cost to participate in this lawsuit?
No, participating in this class action incurs no costs for class members, allowing broader access to potential recovery.
